CClinicalTrials.gg
Sign In
RecruitingNCT07624474MEPS-FrUpdated Jun 12, 2026

Validation, in a Pediatric Population, of a French Translation of the MEPS/MEPI Score

An interventional study of MEPS-Fr version in MEPI, MEPS and PREE, sponsored by Centre Hospitalier Universitaire, Amiens. Recruiting at 1 site in France. Open to participants aged 4 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-06-12.

Sponsored by Centre Hospitalier Universitaire, Amiens · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Apr 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
170
Allocation
Non-randomized
Ages
4 Years to 17 Years
Sex
All
01

Study summary

The MEPI (Modified Elbow Performance Index) or MEPS (Modified Elbow Performance Score) is a multidimensional assessment scale for elbow pain and function. This score is widely used in scientific literature, particularly for post-traumatic and post-operative evaluation, including in many French-language studies. However, no French translation of this score has undergone quality criteria verification and validation in a pediatric population.

02

Conditions studied

  • MEPI
  • MEPS
  • PREE
  • DASH Elbow

Keywords

  • MEPI
  • MEPS
  • PREE
  • DASH elbow
03

In context

Lead sponsor

Centre Hospitalier Universitaire, Amiens is the lead sponsor of 576 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pre-test volunteer group:
  • Patients aged 4 to 17 years followed in the department without an elbow injury
  • Follow-up schedule compatible with the study protocol
  • No objection from a parent or legal guardian, with the child's consent if age permits
  • Test volunteer group:
  • Patients aged 4 to 17 years followed in the department with a diagnosis of an elbow injury
  • Follow-up schedule compatible with the study protocol
  • No objection from a parent or legal guardian, with the child's consent

Exclusion criteria

Exclusion Criteria:

  • Pre-test volunteer group:
  • Language barrier, lack of understanding of French
  • Refusal to participate
  • Confounding factor impairing function
  • Opposition of parent or legal guardian and/or refusal of child if age permits
  • Test volunteer group:
  • Language barrier, lack of understanding of French
  • Refusal to participate
  • Confounding factor impairing function
  • Opposition of parent or legal guardian and/or refusal of child if age permits
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
170 participants (estimated)

Study arms

  • Active comparator
    pre-test

    patients without elbow injury

    Device: MEPS-Fr version

  • Experimental
    validation test

    patients treated either orthopedically or surgically for an elbow injury.

    Device: MEPS-Fr version

Interventions

  • DeviceMEPS-Fr version

    The MEPS-Fr version will be tested on 120 patients treated either orthopedically or surgically for an elbow injury

06

What researchers measure

Primary outcomes

  1. MEPS-FR score

    Mayo Elbow Performance Score (MEPS)

    Time frame: day 0

  2. MEPS-FR score

    Mayo Elbow Performance Score (MEPS)

    Time frame: 6 weeks

  3. MEPS-FR score

    Mayo Elbow Performance Score (MEPS)

    Time frame: 12 weeks

  4. PREE Score

    The Patient-Rated Elbow Evaluation is PREE

    Time frame: day 0

  5. PREE Score

    The Patient-Rated Elbow Evaluation is PREE

    Time frame: 6 weeks

  6. PREE Score

    The Patient-Rated Elbow Evaluation is PREE

    Time frame: 12 weeks

  7. quick DASH Score

    DASH is Disabilities of the Arm, Shoulder and Hand

    Time frame: day 0

  8. quick DASH Score

    DASH is Disabilities of the Arm, Shoulder and Hand

    Time frame: 6 weeks

  9. quick DASH Score

    DASH is Disabilities of the Arm, Shoulder and Hand

    Time frame: 12 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07624474
Lead sponsor
Centre Hospitalier Universitaire, Amiens
Responsible party
Sponsor
First posted
Jun 3, 2026
Start date
Apr 13, 2026
Primary completion
Apr 2028 (estimated)
Completion
Jul 2028 (estimated)
Last update
Jun 12, 2026

Study contacts

Céline KLEIN, Pr
Contact
klein.celine@chu-amiens.fr
33+3 22 08 80 00 ext. 36 186

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Centre Hospitalier Universitaire, Amiens

Start the discussion